Aortyx participated in the second edition of
the IQS Tech Fest, organized by IQS Tech Factory at the Damm Factory in
Barcelona. This festival is a European meeting point for the next generation of
industrial startups. Aortyx presented at the Investment Forum and held meetings
with a number of angel investors, and used the opportunity to interact with
other startups in similar development points.
The JP Morgan Healthcare conference is the most
important networking event for biotech and medtech companies. Started in 2008,
the event, held at the Hilton San Francisco Union Square, brings more than
3,500 decision makers from more than 2,000 biotech, financial, and pharma
companies to network and share insights on industry trends through plenary
sessions, fireside chats, and panels.
Aortyx was present, thanks to the support of FIPSE’s
International Acceleration Program, to interact with a number of stakeholders.
Dr. Jordi Martorell attended to more than 30 meetings in 3 exciting days with
investors, business developers, clinical manufacturing organizations and
clinical research organizations. As a result, the roadmap from prototype to
market was polished and adapted to the highest standards and the team was ready
to start the Seed Round.
The Barcelona Healthcare
Investment Forum is a meeting point for Biotech and Medtech entrepreneurs and
investors, hosted by the Official Medical Association from Barcelona (COMB).
After more than 20 editions, this forum has positioned itself as a benchmark in
the Catalan biomedical ecosystem, promoting innovation and entrepreneurship
among the medical community.
Aortyx presented
for the first time to a broad audience who was excited to learn about the
technology. Many meetings with potential investors and industrial partner have
succeeded the presentation, with new to come from those meetings in 2019.
Aortyx was founded in October 2018. Co-founders are Dr. Jordi Martorell, Ms. Noemí Balà, Dr. Vicenç Riambau and Dr. Salvador Borrós. Aortyx aims at bringing hope to aortic diseases patients by delivering novel therapies that change their lives.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you agree with it.AgreePrivacy policy